Hudson Bay Capital Management LP recently announced the acquisition of new stake in Genetron Holdings Limited (NASDAQ:GTH). This fresh investment now brings its stake to 1.03% valued currently at $1.05 million. In addition, Maven Investment Partners Ltd. raised its holdings by 0.17 million to 0.17 million shares. And Schonfeld Strategic Advisors LLC has lifted its position by 11.82% or 16916.0 shares – to 0.16 million shares.
With over 0.4 million Genetron Holdings Limited (GTH) shares trading Tuesday and a closing price of $1.17 on the day, the dollar volume was approximately $0.47 million. The shares have shown a negative half year performance of -4.47% and its price on 01/17/23 lost nearly -0.42%. Currently, there are 92.72M common shares owned by the public and among those 87.11M shares have been available to trade.
Will You Miss Out On This Growth Stock Boom?
A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.
And this is just one of our
5 Best Growth Stocks To Own For 2023.
Sponsored
The top 3 mutual fund holders in Genetron Holdings Limited are Robeco Capital Growth Funds SICAV, Vanguard Emerging Markets Stock I, and Vanguard Total International Stoc. Robeco Capital Growth Funds SICAV owns 0.27 million shares of the company’s stock, all valued at over $0.3 million. Vanguard Emerging Markets Stock I sold 39497.0 shares to see its total holdings shrink to 0.24 million shares valued at over $0.27 million and representing 0.27% of the shares outstanding. Vanguard Total International Stoc sold 73025.0 shares to bring its total holdings to over 0.16 million shares at a value of $0.18 million. Vanguard Total International Stoc now owns shares totaling to 0.18% of the shares outstanding.
However, the script later moved the day high at 1.2000, down -0.42%. The company’s stock has a 5-day price change of 1.29% and 45.94% over the past three months. GTH shares are trading 4.91% year to date (YTD), with the 12-month market performance down to -75.67% lower. It has a 12-month low price of $0.73 and touched a high of $4.96 over the same period. GTH has an average intraday trading volume of 150.75K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 11.48%, 18.59%, and -6.25% respectively.
Institutional ownership of Genetron Holdings Limited (NASDAQ: GTH) shares accounts for 14.30% of the company’s 92.72M shares outstanding. Mutual fund holders own 1.07%, while other institutional holders and individual stakeholders account for 4.20% and — respectively.
It has a market capitalization of $98.78M. The earnings-per-share (ttm) stands at -$1.12. Price movements for the stock have been influenced by the stock’s volatility, which stands at 7.30% over the week and 8.02% over the month.
Analysts forecast that Genetron Holdings Limited (GTH) will achieve an EPS of -$0.03 for the current quarter, -$0.03 for the next quarter and -$0.15 for 2023. The lowest estimate earnings-per-share for the quarter is -$0.03 while analysts give the company a high EPS estimate of -$0.03. Comparatively, EPS for the current quarter was -$0.07 a year ago. Earnings per share for the fiscal year are expected to increase by 89.40%, and 20.00% over the next financial year.
Looking at the support for the GTH, a number of firms have released research notes about the stock. Canaccord Genuity stated their Buy rating for the stock in a research note on July 14, 2020, with the firm’s price target at $19. BTIG Research coverage for the Genetron Holdings Limited (GTH) stock in a research note released on July 14, 2020 offered a Buy rating with a price target of $20.
